Clinical Trial Update: A Study To Evaluate An NK-1 Antiemetic For The Prevention Of Post Operative Nausea And Vomiting [Phase 2]

View source ↗

Summary

This entry notes the completion of a Phase 2 clinical trial evaluating an NK-1 antiemetic for prevention of postoperative nausea and vomiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Nausea and Vomiting

Snippet

Sponsor: GlaxoSmithKline | Conditions: Postoperative Nausea and Vomiting, Nausea and Vomiting, Postoperative | Phase 2 | Status: COMPLETED